Jane is an experienced leader with a successful track record in the healthcare industry. Her career spanned a wide variety of functions including R&D, Pharmaceutical Strategy, Strategic Marketing and Market Access and Global Commercial leadership, all within Johnson and Johnson. Her most recent executive position was as Global head of Actelion where she led the organisation whilst integrating the largest ever acquisition made by the company into J&J. Prior positions included Company Group Chairman for Janssen leading the Pharma business across EMEA and prior to that she led the launch of J&J’s HIV portfolio across the globe

Her emphasis has been on driving market leading growth through clear strategy, business model and organisational design, innovation and people engagement.

During her career Jane has been a strong advocate for Diversity and Inclusion acting as sponsor for the J&J Womens Leadership Initiative in J&J and speaking in external fora on the topic. Her passion for Sustainability drove her to advocate for more sustainable practices in J&J and her desire to be actively engaged in J&J’s CSR activities led her to Chair the Johnson and Johnson Foundation in EMEA for several years prior to her retirement. She remains actively involved in the foundation.

Jane holds 2 FTSE NED positions at Johnson Matthey and BAE systems and 2 non profitBoard positions at The TB Alliance and The White Ribbon Alliance